Universität Bern
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1834-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.unibe.ch
Impact of Microparticles on Postoperative Complications in Surgical Patients
Completed
- Conditions
- Neoplasm, HepaticColorectal NeoplasmsPancreatic Neoplasms
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2011-09-07
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 108
- Registration Number
- NCT00677781
- Locations
- 🇨🇭
Department of visceral and transplant surgery, Bern University Hospital, Bern, Switzerland
Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation
Completed
- Conditions
- Eosinophilic EsophagitisEsophageal StenosisEsophageal DilationEsophageal Dilatation
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2009-12-29
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 207
- Registration Number
- NCT00667524
- Locations
- 🇨🇭
Dpt of Gastroenterology, Bern University Hospital, Bern, Switzerland
Point of Care Coagulation Testing in Patients Undergoing Major Surgery
Phase 3
Completed
- Conditions
- Blood Loss, Surgical
- Interventions
- Device: Coagucheck XS Plus (Point of care monitor of coagulation intraoperative)Procedure: Control Intervention
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 228
- Registration Number
- NCT00656396
- Locations
- 🇨🇭
University Hospital Bern, Bern, Switzerland
Steroid Before Thyroidectomy
Not Applicable
Completed
- Conditions
- Thyroid Surgery for Benign Disease
- Interventions
- Drug: PlaceboDrug: Dexamethason Helvepharm ®
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2008-06-09
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 72
- Registration Number
- NCT00619086
- Locations
- 🇨🇭
Department of visceral- and transplant surgery, Bern, Switzerland
Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent
Phase 4
Completed
- Conditions
- Coronary Heart Disease
- Interventions
- Device: EndeavorTM (Zotarolimus-Eluting Stent)Device: Helistent Titan2 (Titanium coated stent)
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 303
- Registration Number
- NCT00492908
- Locations
- 🇨🇭
Department of Cardiology, University Hospital Bern, Bern, Switzerland
Sorafenib With TACE to Treat Hepatocellular Carcinoma
Phase 1
Completed
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Transarterial chemoembolisation with doxorubicin
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2010-11-02
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 21
- Registration Number
- NCT00478374
- Locations
- 🇨🇭
Inselspital, Bern, Switzerland
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization
Phase 4
Completed
- Conditions
- Coronary Heart Disease
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2006-10-20
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 1012
- Registration Number
- NCT00297661
- Locations
- 🇨🇭
University Hospital Bern, Bern, Switzerland
Spinal Manipulative Therapy for Low Back Pain
Phase 4
Completed
- Conditions
- Low Back Pain
- First Posted Date
- 2006-02-20
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 104
- Registration Number
- NCT00294229
- Locations
- 🇨🇭
Department of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
Immunopharmacological Effects of Rituximab in Atopic Dermatitis
- First Posted Date
- 2005-12-21
- Last Posted Date
- 2008-06-17
- Lead Sponsor
- University of Bern
- Target Recruit Count
- 6
- Registration Number
- NCT00267826
- Locations
- 🇨🇭
University of Bern, Department of Dermatology, Bern, Switzerland
© Copyright 2025. All Rights Reserved by MedPath